A retrospective study of JELMYTO in managing patients with larger volume disease where initial tumor burden may not be amenable to complete mechanical ablation or renal preservation
Latest Information Update: 12 Jul 2023
At a glance
- Drugs Mitomycin (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
Most Recent Events
- 12 Jul 2023 New trial record
- 10 Jul 2023 According to a UroGen Pharma media release, data from the trial published in the Urologic Oncology: Seminars and Original Investigations online.
- 10 Jul 2023 Results presented in the UroGen Pharma Media Release.